AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
183.60
-5.33 (-2.82%)
At close: Mar 20, 2026, 4:00 PM EDT
183.80
+0.20 (0.11%)
After-hours: Mar 20, 2026, 7:47 PM EDT
AstraZeneca Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for AstraZeneca in the last 12 months.
Price Target: n/a
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for AstraZeneca is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Initiates n/a | Hold → Strong Buy | Initiates | n/a | n/a | Oct 27, 2025 |
| UBS | UBS | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 13, 2025 |
| UBS | UBS | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Nov 20, 2024 |
| Erste Group | Erste Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 11, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $90 → $95 | Strong Buy | Maintains | $90 → $95 | -48.26% | Aug 12, 2024 |
Financial Forecast
Revenue This Year
64.69B
from 58.74B
Increased by 10.13%
Revenue Next Year
68.71B
from 64.69B
Increased by 6.21%
EPS This Year
5.29
from 6.54
Decreased by -19.11%
EPS Next Year
5.95
from 5.29
Increased by 12.50%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 67.7B | 73.8B | |||
| Avg | 64.7B | 68.7B | |||
| Low | 57.3B | 59.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.3% | 14.0% | |||
| Avg | 10.1% | 6.2% | |||
| Low | -2.4% | -8.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.58 | 6.63 | |||
| Avg | 5.29 | 5.95 | |||
| Low | 4.65 | 5.44 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -14.7% | 25.2% | |||
| Avg | -19.1% | 12.5% | |||
| Low | -28.9% | 2.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.